A top-notch restructuring group, capable of handling the biggest and the most difficult restructuring from either company side or creditors’ side. 
- Chambers USA, Band 1 Bankruptcy/Restructuring (Nationwide and NY)
Healthcare & Pharmaceutical
Our restructuring department fields large, multidisciplinary teams that leverage the resources of our firm as a whole. We act on all sides of cutting-edge restructuring transactions across a range of industries.
-
Chapter 11 Cases of Endo Pharmaceuticals
An ad hoc group of first lien, second lien, and unsecured lenders in the chapter 11 restructuring of Endo Pharmaceuticals, a specialty pharmaceutical company. The group comprised approximately of $3.2 billion, nearly forty percent, of the company’s funded debt.
-
Rite Aid's Restructuring
An ad hoc group of second lien noteholders of Rite Aid Corporation, a full-service pharmacy company providing a broad range of services, including retail pharmacy, PBM, and mail order, across 17 states, in connection with its restructuring of $3.4 billion of total funded debt, including $1.05 billion held by the ad hoc group.
-
SmileDirectClub's Restructuring
An ad hoc committee of holders of unsecured convertible notes issued by SmileDirectClub (“SDC”), which filed for chapter 11 in the Southern District of Texas.
-
Envision Healthcare's Chapter 11 Cases
KKR, as sponsor to Envision Healthcare, in connection with Envision’s chapter 11 cases.
-
Genesis Care's Chapter 11 Cases
KKR, as shareholder and prepetition lender to GenesisCare, an Australia-based operator of cancer treatment centers, in its chapter 11 cases.
-
Clovis Oncology's Chapter 11 Cases and Sale
An ad hoc group of convertible noteholders of Clovis Oncology, a specialty pharmaceutical company, in the company's chapter 11 cases and related sale process.
-
Chapter 11 Cases of the Center for Autism and Related Disorders
Funds or accounts affiliated with Blackstone in the chapter 11 cases of Center for Autism and Related Disorders, one of the nation’s largest treatment providers for individuals diagnosed with autism spectrum disorder.
-
Envision Healthcare Financing
KKR, as sponsor to Envision Healthcare, in connection with Envision’s entry into $2.6 billion, in aggregate, of new senior secured first and second lien financing facilities and its $1.5 billion of related discounted debt repurchase transactions and $3.7 billion refinancing transaction.
-
The Stayton
The successor bond trustee and an ad hoc group of certain holders of Tarrant County Cultural Education Facilities Financial Corporation Retirement Revenue Bonds (The Stayton at Museum Way Project), Series 2020 Bonds, in connection with safeguarding their interests in respect of Series 2020 Bonds and The Stayton, a continuing care retirement community.
-
Bausch Healthcare Spin-Off
An ad hoc group of secured and unsecured creditors of Bausch Health, a multinational healthcare company, in connection with the company’s proposed spin-off of its eyecare business.
-
Mallinckrodt's Restructuring
An ad hoc committee of noteholders of Mallinckrodt, a leading global biopharmaceutical company, in (a) Mallinckrodt’s chapter 11 cases and (b) a prior out-of-court exchange of $495 million of senior unsecured debt for new first lien senior secured notes, on a par-for-par basis.
-
The Medicines Company Chapter 11
The Medicines Company, a leading biopharmaceutical company, as one of the largest unsecured creditors in the chapter 11 cases of Melinta Therapeutics, a pharmaceutical company focused on antibiotic medicines.
-
One Call Medical's Out-of-Court Restructuring
Chatham Asset Management in an out-of-court restructuring of One Call Corporation, a leader in ancillary services for the workers’ compensation industry and ancillary services for Medicare and Medicad, that eliminated nearly $1 billion of the company’s outstanding debt.
-
Trident's Chapter 11 Cases
Silver Point Capital, as postpetition and senior prepetition lender, in the restructuring of Trident and its affiliates, the leading national provider of bedside diagnostic and related health care services, including its chapter 11 cases.
-
Egalet's Prearranged Chapter 11 Cases
An ad hoc group of first lien noteholders of Egalet, a specialty pharmaceutical company, in Egalet's prearranged chapter 11 cases.
-
RCCH HealthCare Partners’ Acquisition of Kennewick Public Hospital District
RCCH HealthCare Partners, a Tennessee-based provider of hospital and healthcare services, in its acquisition of substantially all of the assets of chapter 9 debtor Kennewick Public Hospital District (d/b/a Trios Health).
-
Concordia Healthcare's Restructuring
An ad hoc group of debtholders of Concordia Healthcare, an international specialty pharmaceutical company based in Canada, in the restructuring of the company and its affiliates.
-
Savient Pharmaceutical's Prearranged Chapter 11 Case
The ad hoc committee of senior secured noteholders of Savient Pharmaceuticals, a specialty biopharmaceutical company, in the company’s prearranged chapter 11 case. The company implemented an auction process that resulted in a successful sale of substantially all of the company’s assets pursuant to section 363 of the Bankruptcy Code and the distribution of the sale proceeds to the senior secured noteholders.
-
Omni Home Healthcare's Out-of-Court Restructuring
The sponsors of Omni Home Healthcare, a regional provider of home healthcare services, in the company’s out-of-court restructuring.
-
A Specialty Pharmaceutical Company's Out-of-Court Restructuring
An ad hoc committee of unsecured creditors of a publicly-traded specialty pharmaceutical company in connection with the potential out-of-court restructuring of over $300 million of secured and unsecured debt.
-
PT Network's Credit Facility and Refinancing
PT Network in its $250 million senior secured credit facility in connection with its refinancing of existing indebtedness.
-
Rite Aid Corporation
An ad hoc group of second lien noteholders of Rite Aid Corporation, a full-service pharmacy company providing a broad range of services, including retail pharmacy, PBM, and mail order, across 17 states, in connection with its restructuring of $3.4 billion of total funded debt, including $1.05 billion held by the ad hoc group.
-
Mallinckrodt
An ad hoc committee of noteholders of Mallinckrodt, a leading global biopharmaceutical company, in (a) Mallinckrodt’s chapter 11 cases and (b) a prior out-of-court exchange of $495 million of senior unsecured debt for new first lien senior secured notes, on a par-for-par basis.
-
Envision Healthcare
KKR, as sponsor to Envision Healthcare, in (a) Envision’s chapter 11 cases and (b) in connection with Envision’s entry into $2.6 billion, in aggregate, of new senior secured first and second lien financing facilities and its related $1.5 billion of related discounted debt repurchase transactions and $3.7 billion refinancing transaction.
-
Endo Pharmaceuticals
An ad hoc group of first lien, second lien, and unsecured lenders in the chapter 11 restructuring of Endo Pharmaceuticals, a specialty pharmaceutical company. The group comprised approximately of $3.2 billion, nearly forty percent, of the company’s funded debt.
